Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravascular contrast media. Ionic versus nonionic: current status.

B L McClennan1, H O Stolberg

  • 1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Radiologic Clinics of North America
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the glitz of new equipment.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2001
Same author

Urography survives.

Radiology·2001
Same author

Collaboration between sonologists and sonographers in ultrasonography.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2000
Same author

Standards and guidelines of the CAR on CD-ROM.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2000
Same author

Dying of ignorance.

The Hastings Center report·2000
Same author

What today's department says about the future.

AJR. American journal of roentgenology·2000
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

Low-osmolar contrast media (LOCM) significantly reduce adverse side effects compared to traditional agents. Clinical use confirms LOCM

Area of Science:

  • Radiology and Medical Imaging
  • Pharmacology
  • Biomedical Engineering

Background:

  • Intravascular administration of contrast media can cause serious adverse side effects.
  • These side effects are attributed to osmotoxic and chemotoxic properties of the contrast agent.
  • High-osmolar contrast media (HOCM) have historically posed significant risks.

Purpose of the Study:

  • To highlight the development and benefits of low-osmolar contrast media (LOCM).
  • To discuss the safety and efficacy of LOCM in clinical practice.
  • To examine the evolving risk profiles and future of intravascular contrast agents.

Main Methods:

  • Review of Almén's work on nonionic compounds to reduce osmolality and chemotoxicity.
  • Analysis of worldwide clinical experience with ionic and nonionic LOCM.

Related Experiment Videos

  • Examination of market penetration and physician awareness of LOCM.

    • Main Results:

    • LOCM development reduced osmolality and chemotoxicity significantly.
    • Clinical experience demonstrates LOCM to be safer and more comfortable than HOCM.
    • LOCM use is widespread, with growing awareness of its advantages.

    Conclusions:

    • LOCM represent a major medical advancement, offering improved safety and patient comfort.
    • While cost remains a factor, the shift towards LOCM is unlikely to reverse.
    • Physicians must be informed advocates, balancing scientific benefits with economic considerations for patient care.